Literature DB >> 4691891

[Fuscinopathy in B 12 -avitaminosis].

M Moravec.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4691891     DOI: 10.1007/bf01635764

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  9 in total

1.  [MESOBILIFUSCINURIA IN INCREASED HEME DEGRADATION].

Authors:  M MORAVEC; M NETOUSEK
Journal:  Blut       Date:  1964

2.  Erythrokinetics in pernicious anemia.

Authors:  D H COLEMAN; D M DONOHUE; C A FINCH; A G MOTULSKY; R H REIFF
Journal:  Blood       Date:  1956-09       Impact factor: 22.113

3.  The formation of bile pigment in pernicious anemia.

Authors:  I M LONDON; R WEST
Journal:  J Biol Chem       Date:  1950-05       Impact factor: 5.157

4.  On the origin of bile pigment in normal man.

Authors:  I M LONDON; R WEST; D SHEMIN; D RITTENBERG
Journal:  J Biol Chem       Date:  1950-05       Impact factor: 5.157

5.  [Dipyrrylmethene of hepatic origin].

Authors:  M Netousek; M Moravec
Journal:  Acta Hepatosplenol       Date:  1968 May-Jun

6.  Non-hemoglobin heme intermediates in the biosynthesis of bile pigments.

Authors:  S Schwartz; R Cardinal
Journal:  Medicine (Baltimore)       Date:  1967-03       Impact factor: 1.889

7.  [Secretion of mesobilifuscine in diseases of the liver].

Authors:  M Netousek; M Moravec
Journal:  Acta Hepatosplenol       Date:  1965 Sep-Oct

8.  Studies of the dipyrrylmethene ("fuscin") pigments. II. The contrasting ratios and significance of the fecal urobilinogen and mesobilifuscin in certain anemias.

Authors:  A S GILBERTSEN; V HAWKINSON; C J WATSON
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

9.  Studies of the dipyrrylmethene ("fuscin") pigments. I. The anabolic significance of the fecal mesobilifuscin.

Authors:  A S GILBERTSEN; P T LOWRY; V HAWKINSON; C J WATSON
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.